System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Publications

Journal Article Research Support, Non-U.S. Gov't Epublish 9 citations

PubMed: 37243177 DOI: 10.3390/v15051090

Determinants of Vaccination and Willingness to Vaccinate against COVID-19 among Pregnant and Postpartum Women during the Third Wave of the Pandemic: A European Multinational Cross-Sectional Survey.

Viruses 15(5)

Authors: Emeline Maisonneuve, Eva Gerbier, Fatima Tauqeer, Léo Pomar, Guillaume Favre, Ursula Winterfeld, Anneke Passier, Alison Oliver, David Baud, Hedvig Nordeng, Michael Ceulemans, Alice Panchaud

Affiliations

  • Institute of Primary Health Care (BIHAM), University of Bern, 3012 Bern, Switzerland.
  • Materno-Fetal and Obstetrics Research Unit, Department "Femme-Mère-Enfant", Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.
  • Service of Pharmacy, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.
  • Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, PharmaTox Strategic Research Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, 0316 Oslo, Norway.
  • School of Health Sciences (HESAV), University of Applied Sciences and Arts Western Switzerland, 1011 Lausanne, Switzerland.
  • Swiss Teratogen Information Service, Clinical pharmacology Service, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.
  • Teratology Information Service, Pharmacovigilance Centre Lareb, 5237 MH 's Hertogenbosch, The Netherlands.
  • UK Teratology Information Service, Newcastle upon Tyne Hospitals, NHS Foundation Trust and the UK Health Security Agency, Newcastle upon Tynes NE2 4AB, UK.
  • Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 3000 Leuven, Belgium.
  • L-C&Y, KU Leuven Child & Youth Institute, 3000 Leuven, Belgium.

Abstract

With COVID-19 vaccination hesitancy at around 50% in the obstetric population, it is critical to identify which women should be addressed and how. Our study aimed to assess COVID-19 vaccination willingness among pregnant and postpartum women in Europe and to investigate associated determinants. This study was a cross-sectional, web-based survey conducted in Belgium, Norway, Switzerland, The Netherlands, and United Kingdom (UK) in June-August 2021. Among 3194 pregnant women, the proportions of women vaccinated or willing to be vaccinated ranged from 80.5% in Belgium to 21.5% in Norway. The associated characteristics were country of residence, chronic illness, history of flu vaccine, trimester of pregnancy, belief that COVID-19 is more severe during pregnancy, and belief that the COVID-19 vaccine is effective and safe during pregnancy. Among 1659 postpartum women, the proportions of women vaccinated or willing to be vaccinated ranged from 86.0% in the UK to 58.6% in Switzerland. The associated determinants were country of residence, chronic illness, history of flu vaccine, breastfeeding, and belief that the COVID-19 vaccine is safe during breastfeeding. Vaccine hesitancy in the obstetric population depends on medical history and especially on the opinion that the vaccine is safe and on the country of residence.

MeSH

Pregnancy, Chronic Disease, Cross-Sectional Studies, Vaccines, Virology, Breast Feeding, Vaccination, Covid-19, Influenza Vaccines, Pandemics, History, Postpartum Period, Vaccination Hesitancy

Cited by